Simon Chapman is professor of public health at the University of Sydney. His primary discipline is medical sociology, and within that area he has devoted his career to research and policy advocacy, being most well known for his work in tobacco control. In that field he has won numerous national and international awards, including the 2008 NSW Premier’s Award for Cancer Researcher of the Year, and the 2003 American Cancer Society’s Luther Terry Medal for Outstanding Individual Leadership in tobacco control. He was a board member of the Cancer Council NSW (1997–2006) and is currently a board member of Cancer Australia, the Australian government’s peak advisory body on cancer control. He is a life member of the Australian Consumer’s Association, and was its chairman for five years (1997–2001). One of the core principles of the consumer movement is that people should be given full and comprehensive information to help them make wise choices as consumers, including as consumers of health services like screening. He has contributed to this book in the spirit of that principle.
Alexandra Barratt is associate professor of epidemiology at the University of Sydney, where she teaches in public health, epidemiology and evidence-based medicine. Her research investigates ways to help people make more informed choices about their health care including decisions about screening for breast cancer and prostate cancer. She has produced and presented documentary radio programs for ABC Radio (The Health Report) on cancer screening and evidence-based medicine. She is a double Eureka prizewinner for these programs in 2006 and 2007. She has worked for the National Cancer Institute in the US, the National Breast Cancer Screening Committee in Canada, and the National Breast Cancer Centre in Australia. She sees patients at Family Planning NSW.
Martin Stockler is associate professor in cancer medicine and clinical epidemiology, consultant medical oncologist at the Sydney Cancer Centre, Royal Prince Alfred Hospital and the Concord Repatriation General Hospital, and co-director of Oncology at the National Health and Medical Research Council Clinical Trials Centre at the University of Sydney. He specialises in using drugs to treat people with cancer of the prostate, testis, kidney, bladder and related organs. His research and teaching focus on using clinical trials to improve quality and length of life, prognostication and communication for those affected by cancer.